The HAEMOLAN brand, founded in 2009 (Switzerland), from 307 sister brands and 2214 competing brands. HAEMOLAN is a brand of NOVO-NORDISK A/S, listed on the stock exchange of Francfort. HAEMOLAN belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
NOVO-NORDISK A/S
(HAEMOLAN)
over 5 years*
EUR 641.20